Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group.

Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.

PMID:
21810649
[PubMed - indexed for MEDLINE]
2.

Valproic acid for agitation in dementia.

Lonergan ET, Cameron M, Luxenberg J.

Cochrane Database Syst Rev. 2004;(2):CD003945. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD003945.

PMID:
15106227
[PubMed - indexed for MEDLINE]
3.

Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales.

Tariot PN, Loy R, Ryan JM, Porsteinsson A, Ismail S.

Adv Drug Deliv Rev. 2002 Dec 7;54(12):1567-77. Review.

PMID:
12453674
[PubMed - indexed for MEDLINE]
4.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
5.

An open trial of valproate for agitation in geriatric neuropsychiatric disorders.

Porsteinsson AP, Tariot PN, Erb R, Gaile S.

Am J Geriatr Psychiatry. 1997 Fall;5(4):344-51. Review.

PMID:
9363292
[PubMed - indexed for MEDLINE]
6.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
7.

Pharmacologic management of agitation in Alzheimer's disease.

Profenno LA, Tariot PN.

Dement Geriatr Cogn Disord. 2004;17(1-2):65-77. Epub 2003 Oct 15. Review.

PMID:
14564127
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk